Comfortable leader
12 companies value 65 bn revenue 25 bn margin 3.5% free cash flow 2.5 bn avg. score 2.2
ALC holds 49.3% of the group's value, 2.9x the runner-up
| Rank | Ticker | Company | Share | Value | Revenue | Margin | FCF | 5 years | FCF/px | Yield | What it does · why it is here |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ALC | Alcon Switzerland · score 6.0 | 49% | 32 bn | 11 bn | 5.9% | 1.7 bn | 5.4% | 0.5% | Intraocular lenses, eye surgery and contact lenses · Global leader in eye surgery and contact lenses | |
| 2 | COO | The Cooper Companies United States · score 6.0 | 17% | 11 bn | 4.2 bn | 13.5% | 0.7 bn | 6.1% | — | Contact lenses and women's health devices · Global top 3 in contact lenses | |
| 3 | GKOS | GLAUKOS Corp United States · score 0.2 | 15% | 9.8 bn | 0.6 bn | -30.7% | -0.0 bn | -0.1% | — | Eye treatments for glaucoma, cornea and retina · California — revenue of $613m | |
| 4 | BLCO | Bausch + Lomb Canada · score 1.1 | 9% | 5.9 bn | 5.3 bn | -3.2% | 0.1 bn | 2.3% | — | Contact lenses, eye drops and eye surgery · Century-old brand in contact lenses, eye drops and eye surgery | |
| 5 | WRBY | Warby Parker Inc. United States · score 4.0 | 5% | 3.1 bn | 0.9 bn | 0.8% | 0.0 bn | 0.7% | — | Prescription glasses and sunglasses sold direct to consumers · New York — revenue of $912m | |
| 6 | EYE | National Vision Holdings, Inc. United States · score 5.0 | 2% | 1.4 bn | 2.0 bn | 2.5% | 0.1 bn | 3.5% | — | Optical retail: America's Best and Eyeglass World · Georgia — revenue of $2bn | |
| 7 | STAA | STAAR SURGICAL CO United States · score 2.1 | 2% | 1.1 bn | 0.3 bn | 1.1% | -0.0 bn | -0.6% | — | Implantable lenses for vision correction · California — revenue of $340m | |
| 8 | SGHT | Sight Sciences, Inc. United States · score 0.0 | 1% | 0.5 bn | 0.1 bn | -35.7% | -0.0 bn | -5.1% | — | Devices for glaucoma and dry eye · California — revenue of $83m | |
| 9 | RXST | RxSight, Inc. United States · score 0.0 | 0% | 0.2 bn | 0.1 bn | -38.8% | -0.0 bn | -13.9% | — | Medical technology of adjustable lenses after cataract surgery · California — revenue of $121m | |
| 10 | LNSR | LENSAR, Inc. United States · score 2.2 | 0% | 0.1 bn | 0.1 bn | 57.6% | -0.0 bn | -10.4% | — | Laser systems for cataract and corneal astigmatism · Florida — revenue of $60m | |
| 11 | IRIX | IRIDEX CORP United States · score 0.0 | 0% | 0.0 bn | 0.1 bn | -6.9% | 0.0 bn | -14.8% | — | Ophthalmic medical technology for glaucoma and retina · California — revenue of $52m | |
| 12 | LUCY | Innovative Eyewear Inc United States · score 0.0 | 0% | 0.0 bn | 0.0 bn | -225.3% | -0.0 bn | -105.4% | — | Smart eyewear · Florida — revenue of $3m |
Other industries in the same sector
- Sector overview
- Large-cap pharmaceuticals 9 companies
- Biotechnology 57 companies
- European pharmaceuticals 5 companies
- Lab tools and consumables 37 companies
- Health insurance and services 17 companies
- Medical devices 87 companies
- Specialty pharmaceuticals 77 companies
- Pharmaceutical distribution 7 companies
- Clinical-stage pharmaceuticals 251 companies
- Robotic surgery and advanced medtech 9 companies
- Hospitals 23 companies
- Emerging biotech 5 companies
and 22 industries more
- Molecular testing and advanced diagnostics 42 companies
- Vaccines and mRNA 14 companies
- Clinical-stage biotech 200 companies
- Generics and biosimilars 10 companies
- Animal health 7 companies
- Contract research (CRO) 10 companies
- Consumer health (OTC) 4 companies
- Healthcare software 18 companies
- Rehabilitation and home care 15 companies
- Genomics and sequencing 9 companies
- Structural heart 8 companies
- Medical imaging and hospital equipment 16 companies
- Diagnostic labs 6 companies
- Medical and dental supply distribution 3 companies
- Diabetes monitoring 9 companies
- Pharmaceutical royalties 5 companies
- Respiratory and sleep therapy 9 companies
- Orthopedic implants 17 companies
- Dialysis 3 companies
- Telehealth and digital health 12 companies
- Dental 4 companies
- Medical and recreational cannabis 16 companies
What this is. A catalogue, not a guide. Every industry with stocks listed on the NYSE or NASDAQ, the companies contending for its leadership, what each one does according to its own annual report, and the balance sheet it filed with the SEC.
The score runs from 0 to 10 and compares each company with every other one in the almanac on cash generation, profitability, debt, dividends and consistency over the last five years. The higher it is, the better the company fares in that comparison. Curious how much each part weighs? Ask at the bottom of the page.
The score runs from 0 to 10 and compares each company with every other one in the almanac on cash generation, profitability, debt, dividends and consistency over the last five years. The higher it is, the better the company fares in that comparison. Curious how much each part weighs? Ask at the bottom of the page.